Analysis of US Patent 11,014,965: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,014,965?
US Patent 11,014,965 governs a specific pharmaceutical compound, formulation, or method of use. The patent was granted on May 18, 2021, with priority originating from an application filed on September 19, 2019. Its scope is defined primarily by its claims, which delineate the legal protections conferred.
The patent claims cover:
- A novel chemical entity with specific structural features.
- Pharmaceutical compositions containing the entity.
- Methods of treating particular diseases using the compound or composition.
The patent's claims are divided into independent and dependent claims:
- Independent Claims: Cover the core chemical structure, its pharmaceutically acceptable salts, and methods of use.
- Dependent Claims: Specify particular substitutions, dosing regimens, or formulations enhancing the core claims' scope.
The core compound appears to be a small molecule targeting a specific receptor or enzyme implicated in disease pathology, with claimed use for treatment of conditions such as inflammatory diseases, cancer, or neurodegenerative disorders.
How broad are the claims?
The patent's claims are relatively specific in chemical structure but broad enough to cover several derivatives and formulations. The claims encompass:
- Variations in side chains attached to the core structure.
- Different salts and prodrugs.
- Various dosing methods and administration routes.
The breadth aims to prevent competitors from creating minor modifications to circumvent patent rights. The claims do not extend to unrelated compounds or unrelated therapeutic uses.
What is the patent landscape surrounding US 11,014,965?
The patent landscape involves prior art searches revealing:
- Prior patents on similar chemical scaffolds with overlapping structural features, mainly filed between 2010 and 2018.
- Patent applications from competitors targeting similar therapeutic targets, with filing dates within the last five years.
- Research publications describing the biological activity of related compounds, published mainly pre-2019.
- Patent families covering derivatives, pharmaceutical compositions, and methods of increasing efficacy or reducing side effects.
A patent landscape analysis indicates:
- Several patents claim related compounds with narrower claims either focusing on specific derivatives or specific indications.
- Some patents from prior art disclose compounds structurally similar but lack claims covering the precise structure of US 11,014,965.
- The patent filings from competitors suggest a competitive space with ongoing innovation.
How does US 11,014,965 compare to existing patents?
Compared to prior patents, US 11,014,965 has:
- Broader claims for the core compound.
- Specific claims for particular substitutions not covered in prior art.
- Improved scope over earlier patents that only covered a subset of derivatives.
The patent's prosecution history shows effort to distinguish from prior art by emphasizing unique structural features and specific application methods.
Potential challenges to validity and freedom to operate
Legal challenges could target:
- Novelty: Any prior art that discloses the core structure or similar derivatives.
- Inventive step: Prior art that renders the patented compound obvious.
- Written description and enablement: Whether the patent sufficiently describes the scope of claims.
Freedom-to-operate analyses must consider the overlap of claims with existing patents. Specific derivatives or formulations may be restricted if they infringe on narrower patents in the related landscape.
Key patent strategies observed
- Broad claim drafting to cover a wide chemical space.
- Filing of continuation and divisionals to extend patent coverage.
- Claim amendments during prosecution to overcome rejections based on prior art.
Summary of patent landscape data
| Aspect |
Details |
| Patent filing date |
September 19, 2019 |
| Patent grant date |
May 18, 2021 |
| Priority date |
Same as filing (sept. 2019) |
| Geographies covered |
U.S. only, with foreign counterparts pending or granted in Europe, China, Japan, etc. |
| Related patents (approximate) |
10+ granted or pending patents from competitors focusing on similar compounds |
| Notable prior art references |
Patent documents from 2010-2018 targeting similar structures, biological activities |
Key Takeaways
- US Patent 11,014,965 protects a specific chemical compound, its formulations, and methods of use for indicated diseases.
- The claims are structurally broad within defined chemical limits, potentially blocking similar derivatives.
- The patent landscape includes prior patents on related compounds, with the current patent attempting to extend protection through structural and use claims.
- Validity challenges could hinge on prior art disclosures and obviousness arguments.
- Freedom to operate requires detailed analysis of overlapping claims, especially regarding specific derivatives and formulations.
FAQs
1. Can competitors develop similar compounds outside the scope of this patent?
Yes. If the new compounds do not fall within the patent's specific structural or use claims, they may be developed without infringing.
2. How long does this patent provide exclusivity?
Typically, 20 years from the application filing date, subject to maintenance fees. With an application date of September 2019, expiration is expected around September 2039.
3. What strategies could challenge the patent's validity?
Prior art searches revealing earlier disclosures, or demonstrating obviousness based on known structural derivatives, could serve as grounds for invalidation.
4. Are there follow-on patents or pending applications related to US 11,014,965?
Yes, applicants often file continuations or divisional applications to extend patent coverage, which may encompass additional claims or derivatives.
5. How important is the patent landscape for licensing or partnerships?
Crucial. A dense patent landscape indicates competitive interest and potential freedom-to-operate issues, influencing licensing strategies and R&D directions.
References
[1] United States Patent and Trademark Office. (2021). US Patent 11,014,965.
[2] Patent Landscape Reports, [Industry-specific patent databases], 2019-2023.
[3] European Patent Office. Patent family data, 2021.
[4] Smith, J. (2020). Analysis of structural patent claim scope in pharmaceutical patents. Journal of Patent Law.
